Cue Biopharma Inc. (CUE) stock surges during after-hour session, given no recent update.
Cue Biopharma Inc. (NASDAQ: CUE) stock declined by 2.61% at last close whereas the CUE stock price gains by 6.78% in the after-hours trading session. Cue Biopharma which is a clinical-stage pharmaceutical firm develops a new class of injectable biologics that specifically engage and regulate specific T cells directly within the body of individuals to […]